Photo Credit: Wildpixel
The Following is a summary of “Clinical Study Status of Diabetic Gastrointestinal Diseases,” Published in the April 2025 Issue of Frontiers in Endocrinology by Fan et al.
Diabetic gastrointestinal disastees impacted qol and impained economy Burdens, Yet Comparhensive Analyses of Related Clinical Trials Were Limited.
Researchers Drived the Retrospective Study to Provide the Scoping Overview of Diabetic Gastrointestinal Disease-Relanted Clinical Trials Registered in ClinicalS.gov and Chictr, Along with High-Quality Trys Pubmed Over the Past 10 Years.
They Searched ClinicalS.gov and chictr databases for trials registered up to June 14, 2024. Addihthally, High-Qality Trials with an impact factor of ≥5 published in published from June 2014 to June 2024 Were included. The Extracted Data Were Organized and Present in Tabular Format.
The Results Showed that diabetic gastroparesis was the primary focus of show studies, with drug interventions being the must frequent. The Majority of the Studies Had Small Sample Sizes (≤100) and Were Randomized Parallel Controlled Trials. BLANDING METHODS VARIED ACROSS 69.01% OF THE STUDIES AND MOST STUDIES Did not include Safety Evaluations or Follow-Up Assessments.
Investigators Concluded that the diagnostic criteria for diabetic gastrointestinal dissees were varied, Most Studies focus on diabetic gastroparesis, and there significant heterogeity in study designs and effectiveness evaluations.
Source: Frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1568552/full
